🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the makers of Tylenol, alleging the firms concealed potential risks that the medication created to pediatric brain development.

The lawsuit follows a month after President Donald Trump promoted an unsubstantiated connection between taking acetaminophen - referred to as paracetamol - during pregnancy and autism spectrum disorder in children.

The attorney general is suing the pharmaceutical giant, which previously sold the drug, the only pain reliever approved for pregnant women, and Kenvue, which currently produces it.

In a declaration, he claimed they "misled consumers by gaining financially from suffering and pushing pills regardless of the potential hazards."

The manufacturer asserts there is no credible evidence connecting acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, intentionally threatening numerous people to line their pockets," Paxton, a Republican, declared.

The company said in a statement that it was "seriously troubled by the spread of false claims on the security of paracetamol and the likely effects that could have on the welfare of women and children in America."

On its website, Kenvue also mentioned it had "consistently assessed the applicable studies and there is no credible data that demonstrates a verified association between consuming acetaminophen and autism."

Organizations speaking for physicians and healthcare providers agree.

ACOG has declared acetaminophen - the key substance in acetaminophen - is one of the few options for women during pregnancy to manage discomfort and elevated temperature, which can pose serious health risks if left untreated.

"In over twenty years of investigation on the consumption of acetaminophen in pregnancy, not a single reputable study has definitively established that the usage of acetaminophen in any period of pregnancy causes neurological conditions in young ones," the association commented.

The lawsuit mentions recent announcements from the former administration in arguing the medication is allegedly unsafe.

In recent weeks, Trump raised alarms from health experts when he advised expectant mothers to "struggle intensely" not to use Tylenol when sick.

The US Food and Drug Administration then published an announcement that physicians should think about restricting the consumption of acetaminophen, while also stating that "a proven link" between the drug and autism spectrum disorder in children has remains unverified.

Health Secretary RFK Jr, who supervises the Food and Drug Administration, had pledged in April to initiate "a massive testing and research effort" that would determine the cause of autism spectrum disorder in a matter of months.

But authorities warned that finding a unique factor of autism spectrum disorder - thought by researchers to be the result of a complicated interplay of genetic and environmental factors - would not be simple.

Autism is a category of lifelong neurodivergence and impairment that influences how individuals experience and relate to the surroundings, and is diagnosed using medical professional evaluations.

In his lawsuit, the attorney general - a Trump ally who is running for federal office - claims Kenvue and J&J "deliberately disregarded and attempted to silence the science" around paracetamol and autism.

The lawsuit aims to force the firms "destroy any marketing or advertising" that claims acetaminophen is reliable for women during pregnancy.

The Texas lawsuit mirrors the concerns of a collection of mothers and fathers of minors with autism and ADHD who took legal action against the manufacturers of Tylenol in recently.

The court dismissed the lawsuit, saying studies from the parents' expert witnesses was inconclusive.